PODD Insulet Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: PODD

Price (delayed)

$188.92

Market cap

$13.19B

P/E Ratio

109.84

Dividend/share

N/A

EPS

$1.72

Enterprise value

$13.93B

Insulet Corporation , headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod ...

Highlights
PODD's price to earnings (P/E) is 99% lower than its last 4 quarters average of 9128.7 and 96% lower than its 5-year quarterly average of 2803.3
The EPS has soared by 91% from the previous quarter
Insulet's quick ratio has decreased by 23% YoY
Sector: Healthcare
Industry: Medical Devices
Website: http://www.myomnipod.com
Peers: ICUI DCTH TNDM DXCM

Key stats

What are the main financial stats of PODD
Market
Shares outstanding
69.83M
Market cap
$13.19B
Enterprise value
$13.93B
Valuations
Price to earnings (P/E)
109.84
Price to book (P/B)
21.71
Price to sales (P/S)
8.47
EV/EBIT
94.42
EV/EBITDA
63.97
EV/Sales
8.94
Earnings
Revenue
$1.56B
EBIT
$147.5M
EBITDA
$217.7M
Free cash flow
$21.4M
Per share
EPS
$1.72
Free cash flow per share
$0.31
Book value per share
$8.7
Revenue per share
$22.3
TBVPS
$33.18
Balance sheet
Total assets
$2.47B
Total liabilities
$1.86B
Debt
$1.42B
Equity
$607.5M
Working capital
$1.02B
Liquidity
Debt to equity
2.34
Current ratio
3.26
Quick ratio
2.12
Net debt/EBITDA
3.38
Margins
EBITDA margin
14%
Gross margin
65.3%
Net margin
7.7%
Operating margin
8.8%
Efficiency
Return on assets
5.1%
Return on equity
22.4%
Return on invested capital
5.8%
Return on capital employed
7.3%
Return on sales
9.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PODD stock price

How has the Insulet stock price performed over time
Intraday
1.72%
1 week
1.4%
1 month
41.59%
1 year
-34.53%
YTD
-35.83%
QTD
18.45%

Financial performance

How have Insulet's revenue and profit performed over time
Revenue
$1.56B
Gross profit
$1.02B
Operating income
$137.1M
Net income
$120M
Gross margin
65.3%
Net margin
7.7%
Insulet's operating income has surged by 115% YoY and by 61% QoQ
PODD's net income has surged by 91% since the previous quarter
The company's net margin has surged by 79% QoQ
The company's operating margin has surged by 73% YoY and by 52% QoQ

Growth

What is Insulet's growth rate over time

Valuation

What is Insulet stock price valuation
PODD P/E details
P/E
109.84
P/B
21.71
P/S
8.47
EV/EBIT
94.42
EV/EBITDA
63.97
EV/Sales
8.94
PODD's price to earnings (P/E) is 99% lower than its last 4 quarters average of 9128.7 and 96% lower than its 5-year quarterly average of 2803.3
The EPS has soared by 91% from the previous quarter
PODD's price to book (P/B) is 53% less than its 5-year quarterly average of 46.5 and 39% less than its last 4 quarters average of 35.4
The equity is up by 42% YoY and by 10% QoQ
PODD's price to sales (P/S) is 41% lower than its 5-year quarterly average of 14.4 and 36% lower than its last 4 quarters average of 13.2
PODD's revenue is up by 25% year-on-year and by 6% since the previous quarter

Efficiency

How efficient is Insulet business performance
Insulet's return on invested capital has surged by 123% YoY and by 66% QoQ
The ROS has soared by 90% YoY and by 61% from the previous quarter
The return on assets has surged by 82% since the previous quarter
PODD's ROE has soared by 75% QoQ

Dividends

What is PODD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PODD.

Financial health

How did Insulet financials performed over time
The total assets is 33% higher than the total liabilities
Insulet's quick ratio has decreased by 23% YoY
The current ratio has decreased by 18% YoY and by 2.4% from the previous quarter
The company's debt is 134% higher than its equity
The equity is up by 42% YoY and by 10% QoQ
The debt to equity has decreased by 29% YoY and by 7% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.